ESC Professional Premium Access

Valsartan reduces arterial stiffness along with level of soluble ST2 independently of blood pressure changes

Congress Presentation

About the speaker

Doctor Andrzej Tomasik

The Medical University of Silesia, Zabrze (Poland)
0 follower

7 more presentations in this session

Intensive reduction of high normal blood pressures: PRINT-TAHA9 randomized clinical trial

Speaker: Associate Professor A. Attar (Shiraz, IR)

Thumbnail

Results from a phase 1 multiple ascending dose study demonstrating safety and selectivity of aldosterone synthase inhibitor CIN-107

Speaker: Doctor M. Freeman (Boston, US)

Thumbnail

Differentiated approach to the treatment of uncomplicated hypertensive crisis

Speaker: Doctor M. Sadulloeva (Tashkent, UZ)

Thumbnail

Blockade of the renin-angiotensin system as a therapeutic target of NAFLD: results of an experimental model of hypercholesterolemia

Speaker: Professor D. Bertolim Precoma (Campina Grande do Sul, BR)

Thumbnail

Hydrochlorothiazide does not lead to phototoxic reactions and DNA damage in healthy volunteers the HCTox study

Speaker: Doctor F. Goetzinger (Homburg, DE)

Thumbnail

Access the full session

Hypertension - Pharmacotherapy

Speakers: Doctor A. Tomasik, Associate Professor A. Attar, Doctor M. Freeman, Doctor M. Sadulloeva, Professor D. Bertolim Precoma...
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations